An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft-controversial, hot-tempered and…

After a 13-year run at FierceBiotech, I’m stepping aside as editor-in-chief of our plucky, global band of life sciences reporters.

Ipsen has strengthened its connection to Oncodesign, the French oncology specialist that lists Bristol-Myers Squibb among its partners.

In this week's EuroBiotech Report, Metabomed celebrated adding Pfizer to a list of investors that already featured the VC units of Merck KGaA and…

Science Exchange--which runs an outsourcing business service for biopharma and smaller life science groups--has raised $25 million in a new Series B funding…

Moderna Therapeutics, a high-profile private biotech with scores of preclinical projects, is finally moving toward human trials, recruiting one of the world…

WuXi PharmaTech, China's largest CRO, closed an oversubscribed $290 million venture fund, turning its attention to biopharma startups at home and in…

The head of the U.K.'s Trade & Investment in the Ministry of the same name has begun a three-day visit to India to focus on biotech and health…

In no-holds-barred action, the European Medicines Agency has accused India-based CRO GVK Biosciences of systematically faking clinical trials for about 700…

Outsourcing